| Non-invasive assessment of hepatic iron stores by MRI Y Gandon, D Olivie, D Guyader, C Aubé, F Oberti, V Sebille, Y Deugnier The Lancet 363 (9406), 357-362, 2004 | 825 | 2004 |
| Insulin resistance–associated hepatic iron overload MH Mendler, B Turlin, R Moirand, AM Jouanolle, T Sapey, D Guyader, ... Gastroenterology 117 (5), 1155-1163, 1999 | 623 | 1999 |
| A comparison of fibrosis progression in chronic liver diseases T Poynard, P Mathurin, CL Lai, D Guyader, R Poupon, MH Tainturier, ... Journal of hepatology 38 (3), 257-265, 2003 | 606 | 2003 |
| Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications P Nahon, V Bourcier, R Layese, E Audureau, C Cagnot, P Marcellin, ... Gastroenterology 152 (1), 142-156. e2, 2017 | 568 | 2017 |
| Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890 C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ... Journal of hepatology 59 (3), 434-441, 2013 | 557 | 2013 |
| Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study F Carrat, H Fontaine, C Dorival, M Simony, C Hezode, V De Ledinghen, ... The Lancet 393 (10179), 1453-1464, 2019 | 536 | 2019 |
| Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis D Guyader, C Jacquelinet, R Moirand, B Turlin, MH Mendler, J Chaperon, ... Gastroenterology 115 (4), 929-936, 1998 | 397 | 1998 |
| Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 … E Lawitz, E Gane, B Pearlman, E Tam, W Ghesquiere, D Guyader, L Alric, ... The Lancet 385 (9973), 1075-1086, 2015 | 374 | 2015 |
| Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a … M Bourlière, JP Bronowicki, V De Ledinghen, C Hézode, F Zoulim, ... The Lancet Infectious Diseases 15 (4), 397-404, 2015 | 372 | 2015 |
| Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations YM Deugnier, O Loréal, B Turlin, D Guyader, H Jouanolle, R Moirand, ... Gastroenterology 102 (6), 2050-2059, 1992 | 363 | 1992 |
| Prospective randomized trial of chemoembolization versus intra‐arterial injection of 131I‐labeled–iodized oil in the treatment of hepatocellular carcinoma J Raoul, D Guyader, J Bretagne, J Heautot, R Duvauferrier, P Bourguet, ... Hepatology 26 (5), 1156-1161, 1997 | 361 | 1997 |
| Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis C Hézode, H Fontaine, C Dorival, F Zoulim, D Larrey, V Canva, ... Gastroenterology 147 (1), 132-142. e4, 2014 | 330 | 2014 |
| Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases L Falize, A Guillygomarc'h, M Perrin, F Lainé, D Guyader, P Brissot, ... Hepatology 44 (2), 472-477, 2006 | 266 | 2006 |
| Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study JP Zarski, N Sturm, J Guechot, A Paris, ES Zafrani, T Asselah, RC Boisson, ... Journal of hepatology 56 (1), 55-62, 2012 | 265 | 2012 |
| Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases YM Deugnier, D Guyader, L Crantock, JM Lopez, B Turlin, J Yaouanq, ... Gastroenterology 104 (1), 228-234, 1993 | 264 | 1993 |
| Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Y Gandon, D Guyader, JF Heautot, MI Reda, J Yaouanq, T Buhé, ... Radiology 193 (2), 533-538, 1994 | 260 | 1994 |
| Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support JL Raoul, D Guyader, JF Bretagne, R Duvauferrier, P Bourguet, ... Journal of Nuclear Medicine 35 (11), 1782-1787, 1994 | 246 | 1994 |
| Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies PJ Pockros, D Guyader, H Patton, MJ Tong, T Wright, JG McHutchison, ... Journal of hepatology 47 (2), 174-182, 2007 | 240 | 2007 |
| Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs P Nahon, R Layese, V Bourcier, C Cagnot, P Marcellin, D Guyader, S Pol, ... Gastroenterology 155 (5), 1436-1450. e6, 2018 | 226 | 2018 |
| Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis L Gailhouste, Y Le Grand, C Odin, D Guyader, B Turlin, F Ezan, Y Désille, ... Journal of hepatology 52 (3), 398-406, 2010 | 189 | 2010 |
